0001209191-12-034155.txt : 20120615 0001209191-12-034155.hdr.sgml : 20120615 20120615182417 ACCESSION NUMBER: 0001209191-12-034155 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120613 FILED AS OF DATE: 20120615 DATE AS OF CHANGE: 20120615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOK JOSEPH C JR CENTRAL INDEX KEY: 0001024003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 12911067 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-06-13 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001024003 COOK JOSEPH C JR C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Stock option (right to buy) 4.05 2012-06-13 4 A 0 30000 4.05 A 2022-06-13 Common Stock 30000 30000 D Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 13, 2012, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2013 Annual Meeting. /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated, attorney-in-fact. 2012-06-15